IL62553A - Vectors comprising dna sequences comprising at least one promoter and operator derived from bacteriophage ypsilon and methods for producing such recombinant dna molecules and cloning vectors - Google Patents

Vectors comprising dna sequences comprising at least one promoter and operator derived from bacteriophage ypsilon and methods for producing such recombinant dna molecules and cloning vectors

Info

Publication number: IL62553A
Authority: IL; Israel
Prior art keywords: vectors; ypsilon; bacteriophage; promoter; producing
Prior art date: 1980-06-06

Application number

IL62553A

Other languages

English (en)

Other versions

IL62553A0 (en

Original Assignee

Biogen Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-06-06

Filing date

1981-04-01

Publication date

1984-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27260930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL62553(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1981-04-01 Application filed by Biogen Nv filed Critical Biogen Nv

1981-06-29 Publication of IL62553A0 publication Critical patent/IL62553A0/xx

1984-12-31 Publication of IL62553A publication Critical patent/IL62553A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/73—Expression systems using phage (lambda) regulatory sequences
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Virology (AREA)
Toxicology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

IL62553A 1980-06-06 1981-04-01 Vectors comprising dna sequences comprising at least one promoter and operator derived from bacteriophage ypsilon and methods for producing such recombinant dna molecules and cloning vectors IL62553A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB8018701		1980-06-06
GB8026661		1980-08-15
GB8028983		1980-09-08

Publications (2)

Publication Number	Publication Date
IL62553A0 IL62553A0 (en)	1981-06-29
IL62553A true IL62553A (en)	1984-12-31

Family

ID=27260930

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL62553A IL62553A (en)	1980-06-06	1981-04-01	Vectors comprising dna sequences comprising at least one promoter and operator derived from bacteriophage ypsilon and methods for producing such recombinant dna molecules and cloning vectors

Country Status (17)

Country	Link
EP (1)	EP0041767B1 (fi)
JP (6)	JPH0787785B2 (fi)
KR (1)	KR860001557B1 (fi)
BG (1)	BG60443B2 (fi)
BR (1)	BR8101972A (fi)
CA (1)	CA1207251A (fi)
DD (1)	DD158918A5 (fi)
DE (1)	DE3177298T2 (fi)
DK (1)	DK171301B1 (fi)
ES (1)	ES500967A0 (fi)
FI (1)	FI811009L (fi)
GR (1)	GR74282B (fi)
IE (1)	IE63126B1 (fi)
IL (1)	IL62553A (fi)
NO (1)	NO811119L (fi)
PH (1)	PH22618A (fi)
YU (1)	YU87581A (fi)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5510472A (en) *	1979-11-21	1996-04-23	Yeda Research And Development Co. Ltd.	Production of recombinant human interferon-beta2
US5554513A (en) *	1979-11-21	1996-09-10	Yeda Research & Development Co. Ltd.	Production of recombinant human interferon-beta2
IL58765A (en) *	1979-11-21	1986-09-30	Yeda Res & Dev	Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
IN156128B (fi)	1980-04-03	1985-05-18	Biogen Nv
IL65475A0 (en) *	1981-04-17	1982-07-30	Meloy Lab	Production of immune interferon and its mrna
EP0068693A3 (en) *	1981-06-16	1983-07-20	Genentech, Inc.	Production of foot and mouth disease vaccine from microbially expressed antigens
JPS5835198A (ja) *	1981-08-28	1983-03-01	Mitsubishi Petrochem Co Ltd	新規ベクター
ZA831854B (en) *	1982-03-26	1984-01-25	Biogen Nv	Small peptides with the specificity of foot and mouth disease viral antigens
WO1983003413A1 (en) *	1982-03-31	1983-10-13	Genetics Inst	Creation of dna sequences encoding modified proinsulin precursors
FR2526661B1 (fr) *	1982-05-13	1986-02-21	Transgene Sa	Nouveaux vecteurs d'expression de la proteine antigenique de la rage et leur application a la preparation de vaccins
US4582800A (en) *	1982-07-12	1986-04-15	Hoffmann-La Roche Inc.	Novel vectors and method for controlling interferon expression
CA1209501A (en) *	1982-09-16	1986-08-12	Nikos Panayotatos	Expression vector
CA1341012C (en) *	1982-09-27	2000-06-06	Biogen, Inc.	Dna sequences, recombinant dna molecules and processes for producing swine growth hormone-like polypeptides
EP0121569B1 (en) *	1982-10-08	1990-08-22	Kyowa Hakko Kogyo Co., Ltd.	Novel vector
DE3482840D1 (de) *	1983-01-21	1990-09-06	Transgene Sa	Expressionsvektoren und deren verwendung zur herstellung eines proteins mit menschlicher alpha-antitrypsin-aktivitaet.
FR2539758B1 (fr) *	1983-01-21	1985-11-15	Transgene Sa	Nouveaux vecteurs d'expression et leur application a la preparation d'une proteine ayant l'activite de l'antitrypsine-a1 humaine
GB8308235D0 (en) *	1983-03-25	1983-05-05	Celltech Ltd	Polypeptides
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
DE3319242A1 (de) *	1983-05-27	1984-11-29	Battelle-Institut E.V., 6000 Frankfurt	Verfahren und plasmid zur steuerung der expression von klonierten genen
BG49718A3 (en) *	1983-07-15	1992-01-15	Bio- Technology General Corp	Method for preparing of polypeptid with superoxiddismutasne activitty
US5670371A (en) *	1983-07-15	1997-09-23	Bio-Technology General Corp.	Bacterial expression of superoxide dismutase
US5162216A (en) *	1983-09-23	1992-11-10	Enzon Labs Inc.	Hybrid gene regulatory region operable in E. coli
FR2556365B1 (fr) *	1983-12-09	1987-07-31	Transgene Sa	Vecteurs de clonage et d'expression de l'interferon-g, bacteries transformees et procede de preparation de l'interferon-g
US4711845A (en) *	1984-08-31	1987-12-08	Cetus Corporation	Portable temperature-sensitive control cassette
JP2595205B2 (ja) *	1984-02-08	1997-04-02	カロインコーポレイション	発現カセット
US5126252A (en) *	1984-08-27	1992-06-30	Bio-Technology General Corp.	Expressions vectors containing Lambda PL promoter and T1 T2 RNA termination sequence, plasmids containing the vectors, hosts containing the plasmids and relatedmethods
US5081020A (en) *	1984-08-27	1992-01-14	Bio-Technology General Corp.	Expression vectors containing λPL promoter, T1 T2 rRNA termination sequence and origin of replication derived from a constitutive high copy number plasmid hosts and related methods
US5059529A (en) *	1984-08-27	1991-10-22	Bio-Technology General Corp.	Stabilized expression vectors containing λPL promoter and the gene for the cI434 repressor, plasmids containing the vectors, hosts containing the plasmids and related methods
US5143836A (en) *	1984-08-27	1992-09-01	Bio-Technology General Corp.	Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda pl promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof
CA1340597C (en) *	1984-08-27	1999-06-22	Haim Aviv	Expression vectors containing pl promoter, and engineered restriction site for convenient replacement of ribosomal binding site, plasmids containing the vectors, hosts containing the plasmids and related methods
US5112744A (en) *	1984-08-27	1992-05-12	Bio-Technology General Corp.	Plasmids for the production of human Cu-Zn superoxide dismutase, bacterial hosts containing the plasmids and methods for production and recovery of such superoxide dismutase
US5759816A (en) *	1984-08-27	1998-06-02	Bio-Technology General Corp.	Expression vectors containing λPL promoter and T1 T2 rRNA termination sequence plasmids containing the vectors hosts containing the plasmids and related methods
US5162217A (en) *	1984-08-27	1992-11-10	Bio-Technology General Corp.	Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda PL promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof
US4766066A (en) *	1984-09-27	1988-08-23	Eli Lilly And Company	Method of using bacteriophage lambda p1 promoter to produce a functional polypeptide in streptomyces
US5510238A (en) *	1984-10-26	1996-04-23	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Production of human T-cell leukemia (lymphotropic) retrovirus (HTLV-I) envelope protein fragments in bacteria and use in seroepidemiological studies
DE3585690D1 (de)	1984-12-21	1992-04-23	Biogen Inc	Reinigung, herstellung und verwendung von tumor-nekrosisfaktoren.
US5182196A (en) *	1985-10-09	1993-01-26	Biogen, Inc.	Expression systems for overproduction of desired proteins
ATE123526T1 (de) *	1987-08-17	1995-06-15	Hoffmann La Roche	Hochreprimierbare expressionskontrollsequenzen.
JP2003204783A (ja) *	1999-07-19	2003-07-22	Ajinomoto Co Inc	発酵法による目的物質の製造法
US7579005B2 (en)	2005-11-28	2009-08-25	E. I. Du Pont De Nemours And Company	Process for recombinant expression and purification of antimicrobial peptides using periplasmic targeting signals as precipitable hydrophobic tags

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IN156128B (fi) *	1980-04-03	1985-05-18	Biogen Nv
PT73021B (en) *	1980-05-12	1983-10-19	Biogen Nv	Process for producing dna sequences of recombinant dna molecules and polipeptides with specificyty on foot mouth disease as viral antigens

1981
- 1981-04-01 JP JP56047362A patent/JPH0787785B2/ja not_active Expired - Lifetime
- 1981-04-01 DK DK148681A patent/DK171301B1/da not_active IP Right Cessation
- 1981-04-01 EP EP81301413A patent/EP0041767B1/en not_active Revoked
- 1981-04-01 FI FI811009A patent/FI811009L/fi not_active Application Discontinuation
- 1981-04-01 NO NO811119A patent/NO811119L/no unknown
- 1981-04-01 IL IL62553A patent/IL62553A/xx active IP Right Review Request
- 1981-04-01 ES ES500967A patent/ES500967A0/es active Granted
- 1981-04-01 CA CA000374394A patent/CA1207251A/en not_active Expired
- 1981-04-01 KR KR1019810001102A patent/KR860001557B1/ko active
- 1981-04-01 GR GR64560A patent/GR74282B/el unknown
- 1981-04-01 IE IE75781A patent/IE63126B1/en not_active IP Right Cessation
- 1981-04-01 BR BR8101972A patent/BR8101972A/pt unknown
- 1981-04-01 DE DE8181301413T patent/DE3177298T2/de not_active Expired - Lifetime
- 1981-04-01 PH PH25458A patent/PH22618A/en unknown
- 1981-04-02 YU YU00875/81A patent/YU87581A/xx unknown
- 1981-04-02 DD DD81228898A patent/DD158918A5/de unknown
1994
- 1994-02-11 BG BG098457A patent/BG60443B2/bg unknown
1995
- 1995-04-10 JP JP10784695A patent/JP3158951B2/ja not_active Expired - Lifetime
- 1995-04-10 JP JP10784895A patent/JP3158953B2/ja not_active Expired - Lifetime
- 1995-04-10 JP JP10784795A patent/JP3158952B2/ja not_active Expired - Lifetime
1998
- 1998-03-11 JP JP10060225A patent/JPH10304876A/ja active Pending
2000
- 2000-10-13 JP JP2000314383A patent/JP2001136966A/ja active Pending

Also Published As

Publication number	Publication date
CA1207251A (en)	1986-07-08
EP0041767A3 (en)	1982-09-29
JPH0838179A (ja)	1996-02-13
KR830005353A (ko)	1983-08-13
IL62553A0 (en)	1981-06-29
JP3158952B2 (ja)	2001-04-23
PH22618A (en)	1988-10-28
DD158918A5 (de)	1983-02-09
FI811009L (fi)	1981-12-07
ES8302774A1 (es)	1983-01-16
DE3177298T2 (de)	1993-07-01
BR8101972A (pt)	1982-08-17
NO811119L (no)	1981-12-07
JP3158951B2 (ja)	2001-04-23
JPH0838177A (ja)	1996-02-13
YU87581A (en)	1984-04-30
KR860001557B1 (ko)	1986-10-04
ES500967A0 (es)	1983-01-16
JPS5714599A (en)	1982-01-25
JPH0838176A (ja)	1996-02-13
DK148681A (da)	1981-12-07
EP0041767B1 (en)	1993-03-03
DK171301B1 (da)	1996-08-26
IE63126B1 (en)	1995-03-22
EP0041767A2 (en)	1981-12-16
JP2001136966A (ja)	2001-05-22
IE810757L (en)	1981-12-06
DE3177298D1 (de)	1993-04-08
GR74282B (fi)	1984-06-21
JPH0787785B2 (ja)	1995-09-27
BG60443B2 (bg)	1995-03-31
JPH10304876A (ja)	1998-11-17
JP3158953B2 (ja)	2001-04-23

Publication	Publication Date	Title
IL62553A (en)	1984-12-31	Vectors comprising dna sequences comprising at least one promoter and operator derived from bacteriophage ypsilon and methods for producing such recombinant dna molecules and cloning vectors
ZA822855B (en)	1983-03-30	Bacillus cloning vectors,recombinant dna molecules,bacillus hosts transformed with them and methods for expressing foreign dna sequences and producing polypeptides coded thereby
GB8424454D0 (en)	1984-10-31	Recombinant dna cloning vectors
IL60184A0 (en)	1980-07-31	Process for the specific cleavage of protein sequences from proteins
PH21848A (en)	1988-03-17	Dna sequences and recombinant dna molecules
ZA81103B (en)	1982-01-27	Dna sequences ,recombinant dna molecules dna molecules and processes for producing human interferon -like polypeptides
NZ188838A (en)	1982-09-14	Dna coding for microbial expression of mammalian polypeptide recombinant microbial cloning vehicle
PT76726B (en)	1985-12-27	Process for producing the a and b subunits of cholera toxin and related dna sequences and recombinant dna molecules
GB2121054B (en)	1986-02-26	Cloning vectors for expression of exogenous protein
JPS5636499A (en)	1981-04-09	Dna introduced vector
IL70856A0 (en)	1984-05-31	Dna sequences,recombinant dna molecules and processes for producing human interleukin two-like polypeptides
HUT55801A (en)	1991-06-28	Process for producing anti-coagulative peptides marked with radioactivity
GB2009227B (en)	1982-05-26	Process for recovering propane and propene/propane mixtures from the offgases from the hydroformylation of propene
GB2140142B (en)	1986-07-30	Metallurgical vessels including means for injecting gas
IL69591A (en)	1991-01-31	Method for protecting e.coli from a naturally occurring bacteriophage during large scale fermentation and vectors for use therein
DE3477936D1 (en)	1989-06-01	Recombinant dna cloning vector pve1, deletion and hybrid mutants, and recombinant derivatives thereof, products and processes
HUT46359A (en)	1988-10-28	Dna molecules encoding deacetoxy-cefalosporin-c-synthetase and deacetyl-cefalosporin-c-synthetase and recombinant dna vectors
PL313445A1 (en)	1996-07-08	Grb3-3 gene, variants thereof and their use
EP0170266A3 (en)	1988-01-13	Process for producing protein, and vector, recombinant dna and transformant used therefor
GB2018778B (en)	1982-08-25	Vectors derived from lambda bacteriophage
EP0091723A3 (en)	1985-12-18	Transposable cloning vector
HUT40162A (en)	1986-11-28	Recombinant dna expression vectors and process for gene expression
GB8303383D0 (en)	1983-03-16	Sequences recombinant dna molecules
GB2112395B (en)	1985-05-01	Recombinant cloning vector
PT72787A (en)	1981-05-01	Methods for the preparation of improved vectors and for expressing cloned genes

Legal Events

Date	Code	Title	Description
1997-02-18	NG	Permission granted (in opposition proceedings) - sect. 29 and 66 , patents law, 5727-1967